Renin-Angiotensin System Inhibition in Cardiovascular Patients at the Time of COVID19: Much Ado for Nothing? A Statement of Activity from the Directors of the Board and the Scientific Directors of the Italian Society of Hypertension

Cardiovascular diseases, in particular hypertension, as well as the cardiovascular treatment with Renin–Angiotensin System inhibitors such as Angiotensin Converting Enzyme (ACE) inhibitors and Angiotensin Receptor Blockers (ARBs), are claimed once again as mechanisms of Severe Acute Respiratory Synd...

Descripción completa

Detalles Bibliográficos
Autores principales: Iaccarino, Guido, Borghi, Claudio, Cicero, Arrigo F. G., Ferri, Claudio, Minuz, Pietro, Muiesan, Maria Lorenza, Mulatero, Paolo, Mulè, Giuseppe, Pucci, Giacomo, Salvetti, Massimo, Savoia, Carmine, Sechi, Leonardo Alberto, Volpe, Massimo, Grassi, Guido
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Clinical Guidelines and Practice Recommendations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138256/
https://www.ncbi.nlm.nih.gov/pubmed/32266708
http://dx.doi.org/10.1007/s40292-020-00380-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138256/
https://www.ncbi.nlm.nih.gov/pubmed/32266708
http://dx.doi.org/10.1007/s40292-020-00380-3

Ejemplares similares